ArticleOpen forum infectious diseases2023

Pharmacovigilance Study on Eosinophilic Pneumonia Induced by Anti-MRSA Agents: Analysis Based on the FDA Adverse Event Reporting System.

Naoto Okada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.